![]() |
![]() |
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 8.50 | ACUITE BB+ | Positive | Assigned | - |
Bank Loan Ratings | 4.50 | ACUITE BB+ | Positive | Upgraded | - |
Bank Loan Ratings | 19.50 | - | ACUITE A4+ | Assigned |
Bank Loan Ratings | 4.50 | - | ACUITE A4+ | Reaffirmed |
Total Outstanding | 37.00 | - | - |
Total Withdrawn | 0.00 | - | - |
Rating Rationale |
Acuité has upgraded its long-term rating to ‘ACUITE BB+’ (read as ACUITE double B plus) from ‘ACUITE BB’ (read as ACUITE double B) on the Rs.4.50 Cr. bank facilities and reaffirmed its short-term rating of ‘ACUITE A4+’ (read as ACUITE A four plus) on the Rs.4.50 crore bank facilities of Lyophilization Systems India Private Limited (LSIPL). The outlook is ‘Positive’. Acuité has assigned its long-term rating of ‘ACUITE BB+’ (read as ACUITE double B plus) on the Rs.8.50 Cr. bank facilities and its short-term rating of ‘ACUITE A4+’ (read as ACUITE A four plus) on the Rs.19.50 crore bank facilities of Lyophilization Systems India Private Limited. The outlook is ‘Positive’. Rationale for Rating |
About the Company |
Hyderabad-based, Lyophilization Systems India Private Limited (LSIPL) was incorporated in 2003 by Mr. Satya Prasad and Mr. Narendar. LSIPL is engaged in the manufacturing of lyophilizers and its spares. LSIPL also provides post installation services. The company mainly caters to pharma industry. LSIPL also exports to almost 30 countries. |
Unsupported Rating |
Not Applicable |
Analytical Approach |
For arriving at this rating, Acuité has considered the standalone business and financial risk profiles of Lyophilization Systems India Private Limited to arrive at this rating. |
Key Rating Drivers |
Strengths |
Experienced Management The revenue of the company declined by ~17% to Rs.91.11 crore in FY2024 against Rs.110.06 crore in FY2023 and Rs.92.60 Cr. in FY2022. However, in 9MFY2025 the revenue improved to Rs.141.02 Cr. The revenue of the company is volatile as it also dependent on capex in the pharmaceutical industry to an extent. The operating profit margin of the company improved to 13.77 percent in FY2024 as compared to 7.36 percent in FY2023 and 11.67 percent in FY2022. Acuité believes that LSIPL will sustain its existing business risk profile backed by established track record of operations and experienced management. Healthy Financial Risk Profile Acuité believes that the financial risk profile of LSIPL will improve further in near term in absence of any debt funded capex. |
Weaknesses |
Working Capital Intensive Nature of Operations Acuité believes that the working capital operations of the company will remain at similar levels due to nature of the business. |
Rating Sensitivities |
|
Liquidity Position |
Adequate |
LSIPL has an adequate liquidity position marked by the moderate reliance of the company on working capital limits. The bank limit utilization of the company for fund-based limits stood moderate at ~31.55% and for non-fund based limits it stood low at ~3.73% for the last 06 months ending September 2024. LSIPL generated sufficient net cash accruals of Rs.8.75 Cr. in FY2024 against maturing debt obligation of Rs.1.85 Cr. during the same period. LSIPL maintained unencumbered cash and bank balances of Rs.0.10 Cr. as on March 31, 2024. The current ratio stood at 1.22 times as on March 31, 2024. Going ahead, the liquidity position of the company is expected to improve in the near future on account of expected improvement in accruals against nominal repayment obligations and moderate reliance on working capital limits. |
Outlook: Positive |
|
Other Factors affecting Rating |
None |
Particulars | Unit | FY 24 (Actual) | FY 23 (Actual) |
Operating Income | Rs. Cr. | 91.11 | 110.06 |
PAT | Rs. Cr. | 7.34 | 4.25 |
PAT Margin | (%) | 8.05 | 3.86 |
Total Debt/Tangible Net Worth | Times | 0.39 | 0.40 |
PBDIT/Interest | Times | 8.48 | 5.50 |
Status of non-cooperation with previous CRA (if applicable) |
Not Applicable |
Any other information |
None |
Applicable Criteria |
• Default Recognition :- https://www.acuite.in/view-rating-criteria-52.htm • Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
Note on complexity levels of the rated instrument |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Contacts |
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |